109 related articles for article (PubMed ID: 1515073)
1. Conformation and fluctuations of free stefin B: a molecular dynamics study.
Jerala R
Biol Chem Hoppe Seyler; 1992 Jul; 373(7):447-52. PubMed ID: 1515073
[TBL] [Abstract][Full Text] [Related]
2. The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction.
Stubbs MT; Laber B; Bode W; Huber R; Jerala R; Lenarcic B; Turk V
EMBO J; 1990 Jun; 9(6):1939-47. PubMed ID: 2347312
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of Stefin A in complex with cathepsin H: N-terminal residues of inhibitors can adapt to the active sites of endo- and exopeptidases.
Jenko S; Dolenc I; Guncar G; Dobersek A; Podobnik M; Turk D
J Mol Biol; 2003 Feb; 326(3):875-85. PubMed ID: 12581647
[TBL] [Abstract][Full Text] [Related]
4. The three-dimensional solution structure of human stefin A.
Martin JR; Craven CJ; Jerala R; Kroon-Zitko L; Zerovnik E; Turk V; Waltho JP
J Mol Biol; 1995 Feb; 246(2):331-43. PubMed ID: 7869384
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of a human cystatin A variant, cystatin A2-98 M65L, by NMR spectroscopy. A possible role of the interactions between the N- and C-termini to maintain the inhibitory active form of cystatin A.
Tate S; Ushioda T; Utsunomiya-Tate N; Shibuya K; Ohyama Y; Nakano Y; Kaji H; Inagaki F; Samejima T; Kainosho M
Biochemistry; 1995 Nov; 34(45):14637-48. PubMed ID: 7578072
[TBL] [Abstract][Full Text] [Related]
6. The amino acid sequences, structure comparisons and inhibition kinetics of sheep cathepsin L and sheep stefin B.
Ritonja A; Coetzer TH; Pike RN; Dennison C
Comp Biochem Physiol B Biochem Mol Biol; 1996 Jun; 114(2):193-8. PubMed ID: 8759291
[TBL] [Abstract][Full Text] [Related]
7. Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine proteinases.
Pol E; Björk I
Biochemistry; 1999 Aug; 38(32):10519-26. PubMed ID: 10441148
[TBL] [Abstract][Full Text] [Related]
8. Prediction of the secondary structures of stefins and cystatins, the low-molecular mass protein inhibitors of cysteine proteinases.
Sali A; Turk V
Biol Chem Hoppe Seyler; 1987 May; 368(5):493-9. PubMed ID: 3497644
[TBL] [Abstract][Full Text] [Related]
9. Major differences in stability and dimerization properties of two chimeric mutants of human stefins.
Kenig M; Jerala R; Kroon-Zitko L; Turk V; Zerovnik E
Proteins; 2001 Mar; 42(4):512-22. PubMed ID: 11170205
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of inhibition of cysteine proteinases by their protein inhibitors: kinetic studies with natural and recombinant variants of cystatins and stefins.
Machleidt W; Thiele U; Assfalg-Machleidt I; Förger D; Auerswald EA
Biomed Biochim Acta; 1991; 50(4-6):613-20. PubMed ID: 1801731
[TBL] [Abstract][Full Text] [Related]
11. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
Pavlova A; Björk I
Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
[TBL] [Abstract][Full Text] [Related]
12. Structural characterisation of human stefin A in solution and implications for binding to cysteine proteinases.
Martin JR; Jerala R; Kroon-Zitko L; Zerovnik E; Turk V; Waltho JP
Eur J Biochem; 1994 Nov; 225(3):1181-94. PubMed ID: 7957209
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the carboxy terminal part of stefin B does not have a major effect for binding to papain.
Jerala R; Kroon-Zitko L; Kopitar M; Popovic T; Turk V
Biomed Biochim Acta; 1991; 50(4-6):627-9. PubMed ID: 1801733
[TBL] [Abstract][Full Text] [Related]
14. Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.
Pol E; Björk I
Protein Sci; 2001 Sep; 10(9):1729-38. PubMed ID: 11514663
[TBL] [Abstract][Full Text] [Related]
15. Elongation on the amino-terminal part of stefin B decreases inhibition of cathepsin H.
Jerala R; Kroon-Zitko L; Popovic T; Turk V
Eur J Biochem; 1994 Sep; 224(3):797-802. PubMed ID: 7925405
[TBL] [Abstract][Full Text] [Related]
16. Differences in the effects of TFE on the folding pathways of human stefins A and B.
Zerovnik E; Virden R; Jerala R; Kroon-Zitko L; Turk V; Waltho JP
Proteins; 1999 Aug; 36(2):205-16. PubMed ID: 10398367
[TBL] [Abstract][Full Text] [Related]
17. Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases.
Lenarcic B; Krizaj I; Zunec P; Turk V
FEBS Lett; 1996 Oct; 395(2-3):113-8. PubMed ID: 8898076
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the difference in thermodynamic properties between the two cysteine proteinase inhibitors human stefins A and B.
Jerala R; Zerovnik E; Lohner K; Turk V
Protein Eng; 1994 Aug; 7(8):977-84. PubMed ID: 7809037
[TBL] [Abstract][Full Text] [Related]
19. The contribution of N-terminal region residues of cystatin A (stefin A) to the affinity and kinetics of inhibition of papain, cathepsin B, and cathepsin L.
Estrada S; Pavlova A; Björk I
Biochemistry; 1999 Jun; 38(22):7339-45. PubMed ID: 10353845
[TBL] [Abstract][Full Text] [Related]
20. Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition.
Hall A; Dalbøge H; Grubb A; Abrahamson M
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):123-9. PubMed ID: 8471031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
